Innovative drug formulations improve drug delivery by enhancing the bioavailability and targeting of anti-cancer agents. For example, nanoparticle-based therapies can penetrate tumor tissues more effectively, while targeted drugs can home in on specific cancer cells, minimizing damage to healthy tissues. These advancements lead to higher drug concentrations at the tumor site, improving overall treatment efficacy.
